Logo image of ANIP

ANI PHARMACEUTICALS INC (ANIP) Stock Price, Quote, News and Overview

NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD

59.08  -1.56 (-2.57%)

After market: 59.08 0 (0%)

ANIP Quote, Performance and Key Statistics

ANI PHARMACEUTICALS INC

NASDAQ:ANIP (5/21/2025, 8:00:00 PM)

After market: 59.08 0 (0%)

59.08

-1.56 (-2.57%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High77
52 Week Low52.5
Market Cap1.27B
Shares21.57M
Float17.97M
Yearly Dividend0.08
Dividend YieldN/A
PE10.38
Fwd PE8.18
Earnings (Next)08-04 2025-08-04/bmo
IPO05-04 2000-05-04


ANIP short term performance overview.The bars show the price performance of ANIP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

ANIP long term performance overview.The bars show the price performance of ANIP in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of ANIP is 59.08 USD. In the past month the price decreased by -13.59%. In the past year, price decreased by -3.65%.

ANI PHARMACEUTICALS INC / ANIP Daily stock chart

ANIP Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52.69 687.25B
JNJ JOHNSON & JOHNSON 15.24 368.56B
NVO NOVO-NORDISK A/S-SPONS ADR 19.49 302.74B
NVS NOVARTIS AG-SPONSORED ADR 13.57 222.75B
AZN ASTRAZENECA PLC-SPONS ADR 18.73 216.03B
MRK MERCK & CO. INC. 9.88 193.71B
PFE PFIZER INC 7.18 130.67B
SNY SANOFI-ADR 13.78 129.50B
BMY BRISTOL-MYERS SQUIBB CO 6.4 95.65B
GSK GSK PLC-SPON ADR 6.99 77.98B
ZTS ZOETIS INC 26.82 72.01B
HLN HALEON PLC-ADR 22.65 50.05B

About ANIP

Company Profile

ANIP logo image ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. The company is headquartered in Baudette, Minnesota and currently employs 897 full-time employees. The company went IPO on 2000-05-04. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Company Info

ANI PHARMACEUTICALS INC

210 Main Street West

Baudette MINNESOTA 56623 US

CEO: Nikhil Lalwani

Employees: 897

ANIP Company Website

ANIP Investor Relations

Phone: 12186343500

ANI PHARMACEUTICALS INC / ANIP FAQ

What is the stock price of ANI PHARMACEUTICALS INC today?

The current stock price of ANIP is 59.08 USD. The price decreased by -2.57% in the last trading session.


What is the ticker symbol for ANI PHARMACEUTICALS INC stock?

The exchange symbol of ANI PHARMACEUTICALS INC is ANIP and it is listed on the Nasdaq exchange.


On which exchange is ANIP stock listed?

ANIP stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ANI PHARMACEUTICALS INC stock?

14 analysts have analysed ANIP and the average price target is 83.06 USD. This implies a price increase of 40.58% is expected in the next year compared to the current price of 59.08. Check the ANI PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ANI PHARMACEUTICALS INC worth?

ANI PHARMACEUTICALS INC (ANIP) has a market capitalization of 1.27B USD. This makes ANIP a Small Cap stock.


How many employees does ANI PHARMACEUTICALS INC have?

ANI PHARMACEUTICALS INC (ANIP) currently has 897 employees.


What are the support and resistance levels for ANI PHARMACEUTICALS INC (ANIP) stock?

ANI PHARMACEUTICALS INC (ANIP) has a support level at 56.17 and a resistance level at 60.65. Check the full technical report for a detailed analysis of ANIP support and resistance levels.


Is ANI PHARMACEUTICALS INC (ANIP) expected to grow?

The Revenue of ANI PHARMACEUTICALS INC (ANIP) is expected to grow by 30.55% in the next year. Check the estimates tab for more information on the ANIP EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ANI PHARMACEUTICALS INC (ANIP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ANI PHARMACEUTICALS INC (ANIP) stock pay dividends?

ANIP does not pay a dividend.


When does ANI PHARMACEUTICALS INC (ANIP) report earnings?

ANI PHARMACEUTICALS INC (ANIP) will report earnings on 2025-08-04, before the market open.


What is the Price/Earnings (PE) ratio of ANI PHARMACEUTICALS INC (ANIP)?

The PE ratio for ANI PHARMACEUTICALS INC (ANIP) is 10.38. This is based on the reported non-GAAP earnings per share of 5.69 and the current share price of 59.08 USD. Check the full fundamental report for a full analysis of the valuation metrics for ANIP.


What is the Short Interest ratio of ANI PHARMACEUTICALS INC (ANIP) stock?

The outstanding short interest for ANI PHARMACEUTICALS INC (ANIP) is 11.11% of its float. Check the ownership tab for more information on the ANIP short interest.


ANIP Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ANIP. When comparing the yearly performance of all stocks, ANIP turns out to be only a medium performer in the overall market: it outperformed 49.1% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ANIP Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ANIP. ANIP has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ANIP Financial Highlights

Over the last trailing twelve months ANIP reported a non-GAAP Earnings per Share(EPS) of 5.69. The EPS increased by 19.54% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.5%
ROE -1.45%
Debt/Equity 1.38
Chartmill High Growth Momentum
EPS Q2Q%40.5%
Sales Q2Q%43.43%
EPS 1Y (TTM)19.54%
Revenue 1Y (TTM)56.85%

ANIP Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ANIP. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of 26.64% and a revenue growth 30.55% for ANIP


Ownership
Inst Owners95.29%
Ins Owners6.75%
Short Float %11.11%
Short Ratio4.79
Analysts
Analysts84.29
Price Target83.06 (40.59%)
EPS Next Y26.64%
Revenue Next Year30.55%